These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 28812044)

  • 1. Monte Carlo simulations of randomized clinical trials in epilepsy.
    Goldenholz DM; Tharayil J; Moss R; Myers E; Theodore WH
    Ann Clin Transl Neurol; 2017 Aug; 4(8):544-552. PubMed ID: 28812044
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increasing trial efficiency by early reallocation of placebo nonresponders in sequential parallel comparison designs: application to antidepressant trials.
    Boessen R; Knol MJ; Groenwold RH; Grobbee DE; Roes KC
    Clin Trials; 2012 Oct; 9(5):578-87. PubMed ID: 23060319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does accounting for seizure frequency variability increase clinical trial power?
    Goldenholz DM; Goldenholz SR; Moss R; French J; Lowenstein D; Kuzniecky R; Haut S; Cristofaro S; Detyniecki K; Hixson J; Karoly P; Cook M; Strashny A; Theodore WH; Pieper C
    Epilepsy Res; 2017 Nov; 137():145-151. PubMed ID: 28781216
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A multi-dataset time-reversal approach to clinical trial placebo response and the relationship to natural variability in epilepsy.
    Goldenholz DM; Strashny A; Cook M; Moss R; Theodore WH
    Seizure; 2017 Dec; 53():31-36. PubMed ID: 29102709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lamotrigine adjunctive therapy among children and adolescents with primary generalized tonic-clonic seizures.
    Trevathan E; Kerls SP; Hammer AE; Vuong A; Messenheimer JA
    Pediatrics; 2006 Aug; 118(2):e371-8. PubMed ID: 16847080
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploratory analyses of efficacy data from major depressive disorder trials submitted to the US Food and Drug Administration in support of new drug applications.
    Khin NA; Chen YF; Yang Y; Yang P; Laughren TP
    J Clin Psychiatry; 2011 Apr; 72(4):464-72. PubMed ID: 21527123
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Parametric and nonparametric population methods: their comparative performance in analysing a clinical dataset and two Monte Carlo simulation studies.
    Bustad A; Terziivanov D; Leary R; Port R; Schumitzky A; Jelliffe R
    Clin Pharmacokinet; 2006; 45(4):365-83. PubMed ID: 16584284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simulating Clinical Trials With and Without Intracranial EEG Data.
    Goldenholz DM; Tharayil JJ; Kuzniecky R; Karoly P; Theodore WH; Cook MJ
    Epilepsia Open; 2017 Jun; 2(2):156-161. PubMed ID: 28758158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Using routine data to complement and enhance the results of randomised controlled trials.
    Lewsey JD; Leyland AH; Murray GD; Boddy FA
    Health Technol Assess; 2000; 4(22):1-55. PubMed ID: 11074392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Seven-year cost-effectiveness of ProDisc-C total disc replacement: results from investigational device exemption and post-approval studies.
    Radcliff K; Lerner J; Yang C; Bernard T; Zigler JE
    J Neurosurg Spine; 2016 May; 24(5):760-8. PubMed ID: 26824587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An examination of the efficiency of the sequential parallel design in psychiatric clinical trials.
    Tamura RN; Huang X
    Clin Trials; 2007; 4(4):309-17. PubMed ID: 17848492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new population-enrichment strategy to improve efficiency of placebo-controlled clinical trials of antidepressant drugs.
    Merlo-Pich E; Alexander RC; Fava M; Gomeni R
    Clin Pharmacol Ther; 2010 Nov; 88(5):634-42. PubMed ID: 20861834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sample size determination for assessing equivalence based on proportion ratio under a randomized trial with non-compliance and missing outcomes.
    Lui KJ; Chang KC
    Stat Med; 2008 Jan; 27(1):47-67. PubMed ID: 17708514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Demonstration of Group-Level and Individual-Level Efficacy Using Time-to-Event Designs for Clinical Trials of Antiseizure Medications.
    Kerr WT; Kok N; Reddy AS; McFarlane KN; Stern JM; Pennell PB; Stacey W; French J
    Neurology; 2024 Aug; 103(4):e209713. PubMed ID: 39052963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Minimum clinical utility standards for wearable seizure detectors: A simulation study.
    Goldenholz DM; Karoly PJ; Viana PF; Nurse E; Loddenkemper T; Schulze-Bonhage A; Vieluf S; Bruno E; Nasseri M; Richardson MP; Brinkmann BH; Westover MB
    Epilepsia; 2024 Apr; 65(4):1017-1028. PubMed ID: 38366862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospective validation of a seizure diary forecasting falls short.
    Goldenholz DM; Eccleston C; Moss R; Westover MB
    medRxiv; 2024 Jan; ():. PubMed ID: 38260666
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.